Homeopathic Medicine Thuja Occidentalis 200CH, In the Treatment of Urinary Tract Infection- A Randomised, Placebo Controlled Trial
Abstract
Urinary Tract Infection is among the most prevalent infectious disease in human, with substantial financial burden on society. These are the most common bacterial infection in humans, both in the community and hospital setting and have been reported in all socio-economic classes and different age-group in both sexes, but uti is most commonly seen in females due to various clinical conditions like anatomic differences, hormonal effects, malnutrition, poor hygiene, and certain behavioural factors which include delay micturition, sexual activity and the use of diaphragms and. UTI is a second most common infectious presentation in community medical practice. The aim of the study was to study Effectiveness of Thuja Occientalis200CH in the treatment of UTI.
Methods: Single blind placebo-controlled study design has been adopted to know Elaborative study on ‘Effectiveness of Thuja Occidentalis 200CH, In Study of Urinary Tract Infection’. A total number of 80 patients were involved in study having age group 20 to 40 years, both gender and all socioeconomically classes, who fulfilling the inclusion and exclusion criteria. Test group A-40 cases administered homoeopathic medicine Thuja Occidentalis 200CHand Control Group B-40 cases, received Placebo up to Three months with at least four visits.
Result: All data were calculated from the study of 80 individuals. Statistical tests regarding the various parameters were conducted and ratio of cure was found out in relation to the medicine…
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design. Reported size: 80 participants or records.
Read the paper
Related studies
- Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross-sectional, population-based study
- Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China
- The Role of the NLR and PLR in Urinary Tract Infection
- Threat of Antimicrobial Resistance among Pilgrims with Infectious Diseases during Hajj: Lessons Learnt from COVID-19 Pandemic
- Leclercia adecarboxylata urinary tract infection in a patient with bladder cancer and recurrent hematuria
- A Case Series of Staphylococcus lugdunensis Infection in Cancer Patients at an Academic Cancer Institute in the United States
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.